Epivax Oncology Company
Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.
Headquarters:
Providence, Rhode Island, United States
Total Funding:
1524980
Founded Date:
2017-01-01
Investors Number:
5
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-06-12
Employee Number:
1-10
Industry:
Peptides and Proteins
Last Funding Type:
Venture - Series Unknown